Robert Debre Hospital
Paris, 75019, France
NCT Number: NCT04399863
Feasibility study of a therapeutic education program for the patient and his carers, intended for children suffering from acute lymphoblastic leukemia or having received an allograft of hematopoietic stem cells in the pediatric hematology department of Robert Debré hospital ( Paris, APHP). In addition to feasibility, the intermediate effectiveness of the program will be assessed.
Looking for future studies?
Notify Me1 day–18 year
All sexes
Interventional
Not applicable
Paris, 75019, France
This is a pilot feasibility study, of the quasi-experimental before-after, non-randomized, mono-centric type. Feasibility is assessed on process criteria (adoption, reach implementation, satisfaction). Intermediate effectiveness is assessed on the skill level of patients and their caregivers, before, after and at a distance from education. Patients' anxiety levels will also be assessed before, after and at a distance from the program. The level of health literacy will be assessed at the start of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ETOILE is a patient education program, in accordance with French recommendations, which offers to patients and caregivers the opportunity to follow a customized educational training on their disease. Better quality of life and enhanced autonomy are the aim of this program.
Time frame: 6 months
number of patients which joined the programme compared to number of patients referred
Assistance Publique - Hôpitaux de Paris
Other
Feasibility Study of the ETOILE Program, a Therapeutic Education Program in Pediatric Hematology About Acute Lymphoblastic Leukemia and Allogenic Hematopoietic Steam Cells Transplantation, for Patient and Caregivers
Acronym: ETOILE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05784415
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04051216
Hematologic Diseases, Hemic and Lymphatic Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT04745416
COVID-19, Coronaviridae Infections
Ixtapaluca, State of Mexico, Mexico
View Trial DetailsNCT03255668
Hematologic Diseases, Hemic and Lymphatic Diseases
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
View Trial Details